IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 4622 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Article in PDF (146 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   Abstract
   Introduction
   Case report
   Discussion
   References
   Article Figures

 Article Access Statistics
    Viewed4830    
    Printed84    
    Emailed1    
    PDF Downloaded210    
    Comments [Add]    
    Cited by others 6    

Recommend this journal

 


 
CASE REPORT
Year : 2006  |  Volume : 72  |  Issue : 6  |  Page : 440-442

Bullous variant of acral erythema due to methotrexate


1 Department of Dermatology, Pondicherry Institute of Medical Sciences, Pondicherry, India
2 Department of Medical Oncology, Pondicherry Institute of Medical Sciences, Pondicherry, India

Correspondence Address:
Sheela Kuruvila
Department of Dermatology, Pondicherry Institute of Medical Sciences, Ganapathychettikulam, Pondicherry
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.29341

Rights and Permissions

  Abstract 

Chemotherapy-induced acral erythema is a painful erythema of the palms and soles which occurs following chemotherapy. It is usually seen due to cytarabine, doxorubicin and fluorouracil. We present a 40-year-old male patient, a biopsy proven case of squamous cell carcinoma of the floor of the mouth, who developed a bullous variant of acral erythema after a single intravenous dose of methotrexate. He also had fever, buccal mucositis, leucopenia, thrombocytopenia and hyperpigmented macular rash on the face and upper trunk. The bullous variant of acral erythema due to methotrexate has rarely been reported.


Keywords: Acral erythema, Methotrexate


How to cite this article:
Kuruvila S, Dalal M, Sivanesan B. Bullous variant of acral erythema due to methotrexate. Indian J Dermatol Venereol Leprol 2006;72:440-2

How to cite this URL:
Kuruvila S, Dalal M, Sivanesan B. Bullous variant of acral erythema due to methotrexate. Indian J Dermatol Venereol Leprol [serial online] 2006 [cited 2019 Jun 19];72:440-2. Available from: http://www.ijdvl.com/text.asp?2006/72/6/440/29341



  Introduction Top


Methotrexate-induced acral erythema (AE) is an uncommon manifestation of a commonly used drug in medical practice. Other chemotherapeutic agents such as cytarabine, doxorubicin and fluorouracil have been implicated more frequently.[1],[2],[3] The bullous variant is even more uncommon, with sporadic cases having been reported in the literature. The present case is the first report from India.


  Case report Top


A 40-year-old male patient, a biopsy proven case of squamous cell carcinoma of the floor of the mouth, was advised therapy with intravenous methotrexate followed by radiation therapy. He was treated with a single dose of 100mg of intravenous methotrexate. No other chemotherapeutic agents were administered. The patient developed fever within 24h of receiving the injection and burning pain over both soles three days later.

On examination, the patient was found to have severe mucositis involving the lips and oral mucosa [Figure - 1]. There were symmetrical, well-defined erythematous tender macules on the tips of the toes and both soles [Figure - 2]. A few of these macules had central bullae. There was a single erythematous macule on the right palm. There was also a hyperpigmented nonpurpuric macular rash on the face and upper trunk [Figure - 3].

Investigations revealed a total leukocyte count of 900/cu mm and a platelet count of 1.3 lakhs/cu mm which subsequently dropped to 400/cu mm and 15,000 platelets/cu mm respectively over a period of five days. All other investigations including liver function tests were normal. Histopathological examination of the skin lesions could not be done in view of the low platelet count.

The patient recovered within two weeks with supportive therapy for the associated leucopenia and thrombocytopenia.


  Discussion Top


Chemotherapy-induced AE was first described in 1982.[1],[2] This is a distinctive toxic reaction which manifests as a painful AE.[1] It is most commonly seen with high-dose cytarabine, doxorubicin and fluorouracil.[1],[2],[3] The exact mechanism of this reaction is unknown but concentration of the drug by the large number of sweat glands in the palms and soles may explain the localization of the reaction.[1],[2],[4] This hypothesis is supported by the association of AE with chemotherapy-induced syringosquamous metaplasia.[1] This reaction is dose-dependent and may appear with bolus high-dose infusions or long-term low-dose infusions.[2],[5] It is reported mostly in adults and appears 1 to 21 days after the administration of the chemotherapy. It presents as painful, edematous, symmetrical, well-demarcated erythematous macules on the palms and soles. This is often preceded by dysaesthesia and tingling over the palms and soles.[1],[2],[5] In severe cases, bullae involving the palms, soles and the dorsal aspect of the hands and feet may develop.[1] The patient usually recovers without complications although full thickness ischemic necrosis may occur rarely in areas of blistering.[5] Most cases require only supportive care like cold compresses and elevation of the affected limb. Mucositis, thrombocytopenia and leucopenia are well-known adverse effects of methotrexate. However, the association of AE with methotrexate therapy is unusual.[2],[6],[7],[8],[9],[10]

Acral erythema involving the soles of the feet with sparing of the palms and the concomitant presence of diffuse macular lesions over the body has been reported in one case previously.[2] The bullous variant of AE has been commonly described for regimens containing cytarabine. Four case reports of bullous AE due to methotrexate have been published previously.[2],[6],[9],[10] In our patient there was bullous AE involving the soles of both feet with only a single erythematous macule on the right palm in addition to a macular rash on the face and upper trunk, buccal mucositis, leucopenia and thrombocytopenia. Methotrexate was not reinstituted in this patient and the patient was referred for radiotherapy.

 
  References Top

1.Fitzpatrick JE. Mucocutaneous complications of Antineoplastic therapy. In : Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick's Dermatology in General Medicine, Volume 1, 6th ed. New York: McGraw-Hill; 2003; p. 1337-47.  Back to cited text no. 1    
2.Feizy V, Namazi MR, Barikbin B, Ehsani A. Methotrexate-Induced Acral Erythema with Bullous Reaction. Dermatology Online Journal. [cited 2005 Nov 10]. Available from: http://dermatology.cdlib.org.  Back to cited text no. 2    
3.Waltzer JF, Flowers FP. Bullous variant of chemotherapy-induced acral erythema. Arch Dermatol 1993;129:43-5.  Back to cited text no. 3  [PUBMED]  
4.Baack BR, Burgdorf WH. Chemotherapy-induced acral erythema. J Am Acad Dermatol 1991;24:457-61.  Back to cited text no. 4  [PUBMED]  
5.Odom RB, James WD, Berger TG; Andrews Diseases of the skin, 9th ed. WB Saunders: Philadephia; 2000. p. 140.  Back to cited text no. 5    
6.Hellier I, Bessis D, Sotto A, Margueritte G, Guilhou JJ. High-dose methotrexate-induced bullous variant of acral erythema. Arch Dermatol 1996;132:590-1.  Back to cited text no. 6  [PUBMED]  
7.Millot F, Auriol F, Brecheteau P, Guilhot F. Acral erythema in children receiving high- dose methotrexate. Pediatr Dermatol 1999;16:398-400.  Back to cited text no. 7  [PUBMED]  [FULLTEXT]
8.Ikeda H, Kawano H, Kitaura T, Kimura A, Kihira K. Acral erythema associated with high-dose methotrexate infusion. Ann Pharmacother 1999;33:646.  Back to cited text no. 8  [PUBMED]  [FULLTEXT]
9.Morrell DS, Challgren E, Eapen M, Esterly NB. Bullous acral erythema secondary to high-dose methotrexate. J Pediatr Hematol Oncol 2002;24:240.  Back to cited text no. 9  [PUBMED]  [FULLTEXT]
10.Werchniak AE, Chaffee S, Dinulos JG. Methotrexate induced bullous acral erythema in a child. J Am Acad Dermatol 2005;52:S93-5.  Back to cited text no. 10  [PUBMED]  [FULLTEXT]


    Figures

[Figure - 1], [Figure - 2], [Figure - 3]

This article has been cited by
1 Dermatoses in Latin American Immigrant Children Seen in a Universitary Hospital of Spain
María Pérez-Crespo,José Manuel Ramos-Rincón,María Pilar Albares-Tendero,Isabel Betlloch-Mas
Journal of Immigrant and Minority Health. 2014;
[Pubmed] | [DOI]
2 Probable Cytarabine-induced Acral Erythema
Serap Ozmen,Mahmut Dogru,Ceyhun Bozkurt,Ayse Ceyda Kocaoglu
Journal of Pediatric Hematology/Oncology. 2013; 35(1): e11
[Pubmed] | [DOI]
3 Bullous acral erythema: an additional consideration in the differential diagnosis of pauci-inflammatory subepidermal bullae*
Joshua O. Podjasek, Michael J. Camilleri
Journal of Cutaneous Pathology. 2012; 39(3): 382
[VIEW] | [DOI]
4 Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers
Sheng-Hua Yuan,Wei-Hong Ge,Jing Huo,Xiao-Hai Wang
Fundamental & Clinical Pharmacology. 2009; 23(2): 189
[Pubmed] | [DOI]
5 Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers
Yuan, S.-H., Ge, W.-H., Huo, J., Wang, X.-H.
Fundamental and Clinical Pharmacology. 2009; 23(2): 189-196
[Pubmed]
6 Methotrexate-induced drug eruptions: A report of three cases
Xu, Q.-F., Zheng, Y., Guan, L., Lai, W., Lu, C., Wan, M.-J., Gu, Y.-S.
Journal of Clinical Dermatology. 2009; 38(2): 97-98
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow